TENELIGLIPTIN 20mg. IP + METFORMIN 500mg. IP

An antihyperglycemic agent used in the management of type 2 diabetes. (Sanjay Sharma, 2020) Produces absolute reductions in glycated hemoglobin levels. (Xiaoxuan Li, 2018) An effective agent in controlling blood glucose and well-tolerated in patients with type 2 diabetes. (Xiaoxuan Li X. H., 2018) A safe and effective and safe for patients with type 2 diabetes mellitus with renal impairment, or even end-stage renal disease. (Xiaoxuan Li X. H., 2018) Improves blood glucose levels and β-cells function with low risk of hypoglycemia in patients with type 2 diabetes mellitus. (Xiaoxuan Li X. H., 2018) Significantly decreases glycosylated hemoglobin and fasting plasma glucose in type 2 diabetes patients. (Linong Ji, 2021) Exerts a beneficial effect on pancreatic β-cells and improves pancreatic function. (Xiaoxuan Li X. H., 2018) A valuable treatment option for type 2 diabetes mellitus patients who are inadequately glycemic controlled. (Xiaoxuan Li X. H., 2018) A well-tolerated medicine in individuals with any stage of renal impairment from normal to end-stage renal disease. (Masakazu Haneda, 2018)